Jim Simons Neuro Metrix, Inc. Transaction History

Renaissance Technologies LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$0.61 - $0.98 $3,625 - $5,825	5,944 Added 24.64%	30,063 $22,000
Q2 2023 Aug 11, 2023	SELL	$0.92 - $1.48 $12,288 - $19,768	-13,357 Reduced 35.64%	24,119 $24,000
Q1 2023 May 12, 2023	BUY	$1.43 - $2.0 $889 - $1,244	622 Added 1.69%	37,476 $55,000
Q4 2022 Feb 13, 2023	BUY	$1.36 - $1.77 $11,769 - $15,317	8,654 Added 30.69%	36,854 $55,000
Q3 2022 Nov 14, 2022	SELL	$2.97 - $4.1 $47,261 - $65,243	-15,913 Reduced 36.07%	28,200 $79,000

Q2 2022 Aug 12, 2022	BUY	$2.81 - $5.5 $39,297 - $76,917	13,985 Added 46.42%	44,113 $162,000
Q1 2022 May 13, 2022	SELL	$3.42 - $6.37 $391,966 - $730,065	-114,610 Reduced 79.18%	30,128 $125,000
Q4 2021 Feb 11, 2022	BUY	$5.02 - $9.82 $390,244 - $763,387	77,738 Added 116.03%	144,738 $727,000
Q3 2021 Nov 12, 2021	SELL	$3.23 - $24.73 $268,090 - $2.05 Million	-83,000 Reduced 55.33%	67,000 $679,000
Q2 2021 Aug 13, 2021	BUY	$2.72 - $3.8 $142,356 - $198,880	52,337 Added 53.59%	150,000 $512,000
Q1 2021 May 13, 2021	BUY	$3.01 - $5.35 $293,965 - $522,497	97,663 New	97,663 $333,000
Q1 2020 May 14, 2020	SELL	$0.86 - $4.75 $49,339 - $272,517	-57,372 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$2.7 - $5.19 $154,904 - $297,760	57,372 New	57,372 $247,000

320

Ticker NURO
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 7,757,230
Market Cap $28.3M
Description
NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.